Similar articles

• The new COX-2 inhibitors: rofecoxib (Vioxx) and celecoxib (Celebrex).

  Wynn RL. Wynn RL. Gen Dent. 2000 Jan-Feb;48(1):16-20. Gen Dent. 2000. PMID: 11199547 No abstract available.
• The new NSAIDs: cox-2 inhibitors.

  Capriotti T. Capriotti T. Medsurg Nurs. 2000 Dec;9(6):313-7. Medsurg Nurs. 2000. PMID: 11904867 Review. No abstract available.
• [Therapy with preferential and specific COX-2 inhibitors].

  Stichtenoth DO, Frölich JC. Stichtenoth DO, et al. Internist (Berl). 2001 Mar;42(3):421-6. doi: 10.1007/s001080050769. Internist (Berl). 2001. PMID: 11277028 Review. German. No abstract available.
• [Clinical pharmacology of selective inhibitors of cyclooxygenase-2].

  Patrignani P. Patrignani P. Acta Otorhinolaryngol Ital. 2003 Aug;23(4 Suppl 74):13-8, 37-40. Acta Otorhinolaryngol Ital. 2003. PMID: 15058604 Italian. No abstract available.
• [A new NSAID selective COX-2 inhibitor].

  Ledro Cano D, Gómez Rodríguez B, Torres Domínguez Y, Hergueta Delgado P, Herrerías Esteban J, Herrerías Gutiérrez J. Ledro Cano D, et al. Rev Esp Enferm Dig. 1999 Aug;91(8):598. Rev Esp Enferm Dig. 1999. PMID: 10491496 Spanish. No abstract available.